Home  English Website About STADA Sales companies France

International sales activities

France

STADA founded the French sales company EG Labo SAS - Laboratoires Eurogenerics in Paris in 1996.

In France, sales declined slightly in financial year 2010 by 2% to EUR 81.0 million (previous year: EUR 82.4 million) in view of decreased selling prices of some important generics groups as a result of regulatory interventions by French authorities.

Sales of generics in France fell slightly in 2010 by 2% to EUR 76.1 million (previous year: EUR 77.7 million), so that they contributed 94% (previous year: 94%) to STADA’s sales in France. Overall, STADA’s French subsidiary achieved a market share of approx. 4.0% (previous year: approx. 4.3%) in 2010 and thus occupied position 8¹⁾ in the French generics market.

Sales generated by STADA in the local market with branded products decreased by 5% to EUR 4.9 million in financial year 2010 (previous year: EUR 4.7 million). Branded products thus had a share of 6% in 2010 (previous year: 6%) of STADA’s sales in France.

Operating profitability achieved by STADA in the French market in 2010, was, as expected, below Group average.

In the first nine months of 2011 sales increased in France by 2% to EUR 58.1 million
(1-9/2010: EUR 57.0 million). 

1)	STADA estimate based on IMS Health data at ex-factory prices.

1)	Sales below EUR 0.05 million were rounded to EUR 0.0 million.